Prescription HIV Drugs
Recent Posts
- Immunosuppression Linked to HPV-Related Cancers in AIDS Patients (CME/CE, with audio)
- New Antiretroviral Drug Effective as First HIV Treatment (CME/CE)
- New HIV Guidelines Push 'Adherence to Care' (CME/CE)
- FDA Warns of Increased Danger with HIV Drug
- HIV Antibodies May Target Viral Achilles' Heel (CME/CE, with audio)
Random Posts
- Circumcision Reduces HIV Risk, but Only for Men (CME/CE)
- HIV Treatment Numbers Climb
- IAS: Raltegravir Sustains High-level Efficacy in HIV Trial (CME/CE)
- IAS: Simplified HIV Regimen Effective Without Ritonavir (CME/CE)
- IAS: HPV in Men Linked to Increased HIV Risk (CME/CE)
- IAS: HAART Sharply Cuts Mother-to-Child HIV Risk (CME/CE)
- IAS: HAART Sharply Cuts Mother-to-Child HIV Risk (CME/CE, with video)
- Videos Capture HIV in Act of Infection
- IDSA: Flu Vaccine Benefits Moms and Babies (CME/CE)
- Ex-Cons with HIV Likely to Interrupt Treatment
IAS: HIV-Infected Women Predominate Among Late Presenters (CME/CE)
August 02nd, 2009
CAPE TOWN, South Africa — There are significant differences in the demographics of patients who have late presentation of HIV infection and those diagnosed earlier in the disease process, doctors reported here.
- In areas of low prevalence, where HIV may not be the first diagnosis that comes to mind, doctors should remember that older individuals and women may have HIV infection especially if they are from a country where HIV is endemic.
- Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
Of 54 late-presenters, 13 (24%) were women compared with 26 of 251, or about 10% of the non-late group (P<0.01), according to Jurgen van Lunzen, MD, of the Universitatskilinkum Eppendorf in Hamburg, Germany.
“Late presenters tend to be older, they are more often women, and they are from high prevalence countries,” Dr. van Lunzen said in his poster presentation at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
“Pre0
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.